Silencing of human c-myc oncogene expression by poly-DNP-RNA

Oligonucleotides

Volumn 15, Issue 1, 2005, Pages 23-35

  Shen, Long ^a   Zhang, Chongjie ^b,c   Ambrus Jr , Julian L ^b   Wang, Jui H ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; IMMUNOGLOBULIN; OLIGONUCLEOTIDE; POLY 2' O (2,4 DINITROPHENYL) OLIGORIBONUCLEOTIDE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER; CANCER GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE SILENCING; GENE SYNTHESIS; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR REGRESSION;

2,4-DINITROPHENOL; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CODON, INITIATOR; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE SILENCING; GENE THERAPY; GENES, MYC; HUMANS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER;

MINK CELL FOCUS-FORMING VIRUS; MUS MUSCULUS;

EID: 15744373826     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2005.15.23     Document Type: Article

References (43)

1. ADAMS, J.M., HARRIS, A.W., PINKERT, C.A., CORCORAN, L.M., ALEXANDER, W.S., CORY, S., PALMITER, R.D., and BRINSTER, R.L. (1985). The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318, 533-538.
2. AMBRUS, J.L., Jr., CHESKY, L., STEPHANY, D., McFARLAND, P., MOSTOWSKI, H., and FAUCI, A.S. (1990). Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor. J. Immunol. 145, 3949-3955.
3. ASHUN, M.A., HU, Y., KANG, I., LI, C.C., and WANG, J. H. (1996). Inhibition of murine leukemia virus with poly-2′-O-(2,4-dinitrophenyl) poly[A]. Antimicrob. Agents Chemother. 40, 2311-2317.
4. BIRO, S., FU, Y.M., YU, Z.X., and EPSTEIN, S.E. (1993). Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Proc. Natl. Acad. Sci. USA 90, 654-658.
5. BISHOP, J.M. (1982). Retroviruses and cancer genes. Adv. Cancer Res. 37, 1-32.
6. BOUCHARD, C., STALLER, P., and EILERS, M. (1998). Control of cell proliferation by Myc. Trends Cell Biol. 8, 202-206.
7. BRANCH, A.D. (1998). A good antisense molecule is hard to find. Trends Biochem. Sci. 23, 45-50.
8. CHEN, X., SHEN, L., and WANG, J.H. (2004): Poly-2′-DNP-RNAs with enhanced efficacy for inhibiting cancer cell growth. Oligonucleotides 14, 90-99.
9. CHENG, A.J., and VAN DYKE, M.W. (1997). Oligodeoxyribonucleotide length and sequence effects on intramolecular and intermolecular G-quartet formation. Gene 197, 253-260.
10. DANG, C.V., RESAR, L.M., EMISON, E., KIM, S., LI, Q., PRESCOTT, J.E., WONSEY, D., and ZELLER, K. (1999). Function of the c-myc oncogenic transcription factor. Exp. Cell Res. 253, 63-77.
11. DANI, C., BLANCHARD, J.M., PIECHACZYK, M., EL SABOUTY, S., MARTY, L., and JEANTEUR, P. (1984). Extreme instability of myc mRNA in normal and transformed human cells. Proc. Natl. Acad. Sci. USA 81, 7046-7050.
12. ELBASHIR, S.M., HARBORTH, J., LENDECKEL, W., YALCIN, A., WEBER, K., and TUSCHL, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
13. FELSHER, D.W., and BISHOP, J.M. (1999). Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell 4, 199-207.
14. FIRE, A., XU, S.Q., MONTGOMERY, M.K., KOSTAS, S.A., DRIVER, S.E., and MELLO, C.C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811.
15. HANN, S.R., and EISENMAN, R.N. (1984). Proteins encoded by the human c-myc oncogene: Differential expression in neoplastic cells. Mol. Cell Biol. 4, 2486-2497.
16. 1. Nature 328, 445-449.
17. HUDZIAK, R.M., SUMMERTON, J., WELLER, D.D., and IVERSEN, P.L. (2000). Antiproliferative effects of steric blocking phosphorodiamidate morpholino antisense agents directed against c-myc. Antisense Nucleic Acid Drug Dev. 10, 163-176.
18. JAIN, M., ARVANITIS, C., CHU, K., DEWEY, W., LEONHARDT, E., TRINH, M., SUNDBERG, C.D., BISHOP, J.M., and FELSHER, D.W. (2002). Sustained loss of a neoplastic phenotype by brief inactivation of MYC [Comment]. Science 297, 102-104.
19. LIAO, D.J., and DICKSON, R.B. (2000). c-Myc in breast cancer. Endocr. Rel. Cancer 7, 143-164.
20. MACAYA, R.F., WALDRON, J.A., BEUTEL, B.A., GAO, H., JOESTEN, M.E., YANG, M., PATEL, R., BERTELSEN, A.H., and COOK, A.F. (1995). Structural and functional characterization of potent antithrombotic oligonucleotides possessing both quadruplex and duplex motifs. Biochemistry 34, 4478-4492.
21. MAGRATH, I. (1992). Molecular basis of lymphomagenesis. Cancer Res. 52, 5529s-5540s.
22. MARTINEZ, J., PATKANIOWSKA, A., URLAUB, H., LUHRMANN, R., and TUSCHL, T. (2002). Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110, 563-574.
23. McMANAWAY, M.E., NECKERS, L.M., LOKE, S.L., ALNASSER, A.A., REDNER, R.L., SHIRAMIZU, B.T., GOLDSCHMIDTS, W.L., HUBER, B.E., BHATIA, K., and MAGRATH, I.T. (1990). Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide. Lancet 335, 808-811.
24. MIYAGISHI, M., HAYASHI, M., and TAIRA, K. (2003). Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells. Antisense Nucleic Acid Drug Dev. 13, 1-7.
25. NESBIT, C.E., TERSAK, J.M., and PROCHOWNIK, E.V. (1999). MYC oncogenes and human neoplastic disease. Oncogene 18, 3004-3016.
26. RAHMAN, M.H., KANG, I., WATERBURY, R.G., NARANG, U., BRIGHT, F.V., and WANG, J.H. (1996). Selective removal of ribonucleases from solution with covalently anchored macromolecular inhibitor. Anal. Chem. 68, 134-138.
27. ROUSH, W. (1997). Biotechnology: Antisense aims for a renaissance. Science 276, 1192-1193.
28. RU, K., SCHMITT, S., JAMES, W.I., and WANG, J.H. (1999). Growth inhibition and antimetastatic effect of antisense poly-DNP-RNA on human breast cancer cells. Oncol. Res. 11, 505-512.
29. RU, K., TAUB, M.L., and WANG, J.H. (1998). Specific inhibition of breast cancer cells by antisense poly-DNP-oligoribonucleotides and targeted apoptosis. Oncol. Res. 10, 389-397.
30. SCHMIDT, E.V., PATTENGALE, P.K., WEIR, L., and LEDER, P. (1988). Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: A pre-B-cell lymphoma model. Proc. Natl. Acad. Sci. USA 85, 6047-6051.
31. SCHOENENBERGER, C.A., ANDRES, A.C., GRONER, B., VAN DER VALK, M., LEMEUR, M., and GERLINGER, P. (1988). Targeted c-myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription. EMBO J. 7, 169-175.
32. SHEN, L., CHEN, X., and WANG, J.H. (2003). A high-efficacy antisense RIα poly-DNP 21-nt RNA. Antisense Nucleic Acid Drug Dev. 13, 67-74.
33. SIJEN, T., FLEENOR, J., SIMMER, F., THIJSSEN, K.L., PARRISH, S., TIMMONS, L., PLASTERK, R.H., and FIRE, A. (2001). On the role of RNA amplification in dsRNA-triggered gene silencing. Cell 107, 465-476.
34. SKORSKI, T., PERROTTI, D., NIEBOROWSKA-SKORSKA, M., GRYAZNOV, S., and CALABRETTA, B. (1997). Antileukemia effect of c-myc N3′ → P5′ phosphoramidate antisense oligonucleotides in vivo. Proc. Natl. Acad. Sci. USA 94, 3966-3971.
35. SMITH, J.B., and WICKSTROM, E. (1998). Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model. J. Natl. Cancer Inst. 90, 1146-1154.
36. STEVENSON, M. (2004). Therapeutic potential of RNA interference. New Engl. J. Med. 351, 1772-1777.
37. STEWART, T.A., PATTENGALE, P.K., and LEDER, P. (1984). Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38, 627-637.
38. SUZUKI, K., DOI, T., IMANISHI, T., KODAMA, T., and TANAKA, T. (1999). Oligonucleotide aggregates bind to the macrophage scavenger receptor. Eur. J. Biochem. 260, 855-860.
39. WANG, A., and WANG, J.H. (1999). Effective treatment of murine leukemia with antisense poly-2′O-(2,4-dinitrophenyl)-oligoribonucleotides. Antisense Nucleic Acid Drug Dev. 9, 43-51.
40. WATSON, P.H., PON, R.T., and SHIU, R.P. (1991). Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. Cancer Res. 51, 3996-4000.
41. WICKSTROM, E.L., BACON, T.A., GONZALEZ, A., FREEMAN, D.L., LYMAN, G.H., and WICKSTROM, E. (1988). Human promyelocytic leukemia HL-60 cell proliferation and c-Myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc. Natl. Acad. Sci. USA 85, 1028-1032.
42. WOOLF, T.M., MELTON, D.A., and JENNINGS, C.G.B. (1992). Specificity of antisense oligonucleotides in vivo. Proc. Natl. Acad. Sci. USA 89, 7305-7309.
43. XIN, W., and WANG, J.H. (1998). Treatment of duck hepatitis B virus by antisense poly-2′-O-(2,4-dinitrophenyl)-oligoribonucleotides. Antisense Nucleic Acid Drug Dev. 8, 459-468.